跳到主內容
EN 简 A A A 聯絡我們
Youtube Instagram Facebook
預約捐血
預約捐血 圖示

科研刊物

首頁 > 刊物及影片 > 科研刊物
  1. Miller, S., Blood collection in Hong Kong. N Z Nurs J, 1978. 71(5): p. 23-4.
  2. Lin, C.K., et al., A study of hepatitis C virus antibodies and serum alanine amino transferase in blood donors in Hong Kong Chinese. Vox Sang, 1992. 62(2): p. 98-101.
  3. Mak, K.H., et al., Bv: a distinct category of B sub-group among Chinese blood donors in Hong Kong. Transfus Med, 1992. 2(2): p. 129-33.
  4. Mak, K.H., et al., Rh phenotypes of Chinese blood donors in Hong Kong, with special reference to weak D antigens. Transfusion, 1993. 33(4): p. 348-51.
  5. Mak, K.H., et al., A survey of the incidence of Miltenberger antibodies among Hong Kong Chinese blood donors. Transfusion, 1994. 34(3): p. 238-41.
  6. Bhattacherjee, V., et al., Use of NS-4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5 and 6. J Gen Virol, 1995. 76 ( Pt 7): p. 1737-48.
  7. Cheng, G., et al., Haemolytic transfusion reactions due to Mi-antibodies; need to include MiltenbergerIII positive cells in pre-transfusion antibody screening in Hong Kong. Clin Lab Haematol, 1995. 17(2): p. 183-4.
  8. Lin, C.K., et al., Hemolytic transfusion reaction due to Rh antibodies detectable only by manual polybrene and polyethylene glycol technique. Am J Clin Pathol, 1995. 104(6): p. 660-2.
  9. Mak, K.H., et al., The first example of anti-Gya detected in Hong Kong. Immunohematology, 1995. 11(1): p. 20-1.
  10. Lin, C.K., et al., First case of haemolytic disease of the newborn due to anti-Mur in Hong Kong. Clin Lab Haematol, 1996. 18(1): p. 19-22.
  11. Lin, C.K., et al., A case of hydrops fetalis, probably due to antibodies directed against antigenic determinants of GP.Mur (Miltenberger class III) cells. Immunohematology, 1996. 12(3): p. 115-8.
  12. Mak, K.H., et al., Serologic characteristics of H-deficient phenotypes among Chinese in Hong Kong. Transfusion, 1996. 36(11-12): p. 994-999.
  13. Prescott, L.E., et al., Detection and clinical features of hepatitis C virus type 6 infections in blood donors from Hong Kong. J Med Virol, 1996. 50(2): p. 168-75.
  14. Lin, C.K., et al., Report on anti-Dib encountered in two Hong Kong Chinese. Immunohematology, 1997. 13(1): p. 17-9.
  15. Lo, G.H., et al., Emergency banding ligation versus sclerotherapy for the control of active bleeding from esophageal varices. Hepatology, 1997. 25(5): p. 1101-4.
  16. Lin, C.K., et al., The first case of the p phenotype in a Gurkha Nepalese. Immunohematology, 1998. 14(1): p. 30-2.
  17. Lin, C.K., et al., Serologic Characteristics and Clinical Significance of Miltenberger Antibodies among Chinese Patients in Hong Kong. Vox Sanguinis, 1998. 74(1): p. 59-60.
  18. Cheng, G. and C.K. Lin, Will transfusion errors due to human factors ever be eliminated? Hong Kong Med J, 1999. 5(3): p. 304-305.
  19. Liu, H.W., et al., Reduction of platelet transfusion- associated sepsis by short-term bacterial culture. Vox Sang, 1999. 77(1): p. 1-5.
  20. Engelfriet, C.P., et al., Quality assurance, quality control and accreditation. Vox Sang, 2000. 79(4): p. 253-64.
  21. Engelfriet, C.P., et al., The use of the computer cross-match. Vox Sanguinis, 2001. 80(3): p. 184-192.
  22. Zhong, S., et al., Quantitative and genotypic analysis of TT virusinfection in Chinese blood donors. Transfusion, 2001. 41(8): p. 1001-1007.
  23. Lau, J.T., J. Thomas, and C.K. Lin, HIV-related behaviours among voluntary blood donors in Hong Kong. AIDS Care, 2002. 14(4): p. 481-92.
  24. Lee, C.K., et al., Impact of donor arm skin disinfection on the bacterial contamination rate of platelet concentrates. Vox Sang, 2002. 83(3): p. 204-8.
  25. Lin, C.K., Response 20. Vox Sanguinis, 2002. 82(2): p. 87-111.
  26. Reesink, H.W., et al., Prevention of post-transfusion cytomegalovirus: leucoreduction or screening? Vox Sang, 2002. 83(1): p. 72-87.
  27. The future use of pathogen-inactivated platelet concentrates. Vox Sanguinis, 2003. 85(1): p. 54-66.
  28. Georgsen, J., International Forum: 5. Vox Sanguinis, 2003. 85(3): p. 229-230.
  29. Lee, C.K., et al., Estimation of bacterial risk in extending the shelf life of PLT concentrates from 5 to 7 days. Transfusion, 2003. 43(8): p. 1047-52.
  30. Lee, C.K., et al., Prevalence and specificity of clinically significant red cell alloantibodies in Chinese women during pregnancy--a review of cases from 1997 to 2001. Transfus Med, 2003. 13(4): p. 227-31.
  31. Lin, C.K., W.C. Tsoi, and C.K. Lee, International Forum: 7. Vox Sanguinis, 2003. 85(3): p. 232-233.
  32. Li, C.K., et al., Unrelated umbilical cord blood transplantation in children: experience of the Hong Kong Red Cross Blood Transfusion Service. Hong Kong Med J, 2004. 10(2): p. 89-95.
  33. Lin, C.K., Practical approaches to limited resources. Vox Sang, 2004. 87 Suppl 2: p. 172-5.
  34. Coste, J., et al., Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003. Vox Sang, 2005. 88(4): p. 289-303.
  35. Lee, C.K., et al., Prevention of transfusion-transmitted hepatitis E by donor-initiated self exclusion. Transfus Med, 2005. 15(2): p. 133-5.
  36. Yu, P.L., et al., Predicting potential drop-out and future commitment for first-time donors based on first 1.5-year donation patterns: the case in Hong Kong Chinese donors. Vox Sang, 2007. 93(1): p. 57-63.
  37. Lee, C.K., et al., Value of anaerobic culture in bacterial surveillance program for platelet concentrates. Transfusion, 2008. 48(12): p. 2606-11.
  38. Lee, C.K., J. Hong, and A.T. Hung, An update of blood donor recruitment and retention in Hong Kong. Asian J Transfus Sci, 2008. 2(2): p. 47-50.
  39. Reesink, H.W., et al., Donors with a rare pheno (geno) type. Vox Sang, 2008. 95(3): p. 236-53.
  40. Lin, C.K. and S. Thomas, Cost-effectiveness of blood programmes - the Asia Pacific Blood Network perspective. ISBT Science Series, 2009. 4(n2): p. 332-336.
  41. Inventory Management. Vox Sanguinis, 2010. 98(3p1): p. e295-e363.
  42. Hung, I.F., et al., Effect of clinical and virological parameters on the level of neutralizing antibody against pandemic influenza A virus H1N1 2009. Clin Infect Dis, 2010. 51(3): p. 274-9.
  43. Leung, V.K., et al., A probable case of transfusion-transmitted hepatitis B virus infection in an immunosuppressed recipient caused by an occult HBV-infected donor with negative ID-NAT. Transfus Med, 2010. 20(4): p. 276-7.
  44. Reesink, H.W., et al., Haemovigilance for the optimal use of blood products in the hospital. Vox Sang, 2010. 99(3): p. 278-93.
  45. Tadokoro, K., et al., Problems with irradiators. Vox Sang, 2010. 98(1): p. 78-84.
  46. Wong, H.K., et al., Practical limitations of convalescent plasma collection: a case scenario in pandemic preparation for influenza A (H1N1) infection. Transfusion, 2010. 50(9): p. 1967-71.
  47. Wu, J.T., et al., Logistical feasibility and potential benefits of a population-wide passive-immunotherapy program during an influenza pandemic. Proc Natl Acad Sci U S A, 2010. 107(7): p. 3269-74.
  48. Yuen, M.F., et al., Prevalence of occult hepatitis B infection in a highly endemic area for chronic hepatitis B: a study of a large blood donor population. Gut, 2010. 59(10): p. 1389-93.
  49. Benjamin, R.J., et al., Deferral of males who had sex with other males. Vox Sang, 2011. 101(4): p. 339-67.
  50. Hong, J. and A.Y. Loke, Hong Kong young people's blood donation behavior. Asian J Transfus Sci, 2011. 5(1): p. 49-52.
  51. Hung, I.F., et al., Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection. Clin Infect Dis, 2011. 52(4): p. 447-56.
  52. Lee, C.K., Bacterial contamination of blood products. ISBT Science Series, 2011. 6(2): p. 427-431.
  53. Lee, C.K., Application of quality principles in transfusion microbiology. ISBT Science Series, 2011. 6(2): p. 284-286.
  54. Lin, C.K., Harmonization in donor management - the Asia-Pacific perspective. ISBT Science Series, 2011. 6(2): p. 377-380.
  55. Qin, Y.Y., et al., Halogenated POPs and PAHs in blood plasma of Hong Kong residents. Environ Sci Technol, 2011. 45(4): p. 1630-7.
  56. Wu, J.T., et al., Estimating infection attack rates and severity in real time during an influenza pandemic: analysis of serial cross-sectional serologic surveillance data. PLoS Med, 2011. 8(10): p. e1001103.
  57. Wu, J.T., et al., Logistical feasibility and potential benefits of a population-wide passive immunotherapy program during an influenza pandemic. Influenza Other Respir Viruses, 2011. 5 Suppl 1: p. 226-9.
  58. Yuen, M.F., et al., Transmissibility of hepatitis B virus (HBV) infection through blood transfusion from blood donors with occult HBV infection. Clin Infect Dis, 2011. 52(5): p. 624-32.
  59. Cheng, C.K., C.K. Lee, and C.K. Lin, Clinically significant red blood cell antibodies in chronically transfused patients: a survey of Chinese thalassemia major patients and literature review. Transfusion, 2012. 52(10): p. 2220-4.
  60. Lee, C.K., et al., Significant bacterial contamination risk reduction with the use of diversion pouch. Transfus Med, 2012. 22(6): p. 404-8.
  61. Reesink, H.W., et al., Measures to prevent transfusion-related acute lung injury (TRALI). Vox Sang, 2012. 103(3): p. 231-59.
  62. Roth, W.K., et al., International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009. Vox Sang, 2012. 102(1): p. 82-90.
  63. Stormer, M., et al., Establishment of the first international repository for transfusion-relevant bacteria reference strains: ISBT working party transfusion-transmitted infectious diseases (WP-TTID), subgroup on bacteria. Vox Sang, 2012. 102(1): p. 22-31.
  64. Wong, H.K., et al., Risk factor analysis of hepatitis C virus infection among Chinese blood donors in Hong Kong. Transfus Med, 2012. 22(2): p. 133-6.
  65. Chan, H.M., et al., Interdiction of a blood donation containing varicella-zoster virus by donor self-report of chickenpox. Vox Sang, 2013. 104(3): p. 248-9.
  66. Fung, J., et al., Defining normal liver stiffness range in a normal healthy Chinese population without liver disease. PLoS One, 2013. 8(12): p. e85067.
  67. Hung, I.F., et al., Hyperimmune IV immunoglobulin treatment: a multicenter double-blind randomized controlled trial for patients with severe 2009 influenza A(H1N1) infection. Chest, 2013. 144(2): p. 464-73.
  68. Lau, E.H., et al., Predicting future blood demand from thalassemia major patients in Hong Kong. PLoS One, 2013. 8(12): p. e81846.
  69. Lee, C.K., et al., Long-term clinical outcomes after Streptococcus bovis isolation in asymptomatic blood donors in Hong Kong. Transfusion, 2013. 53(10): p. 2207-10.
  70. Lee, C.K., et al., Donors' perspectives on self-deferral of men having sex with men from blood donation. Transfusion, 2013. 53(10 Pt 2): p. 2441-8.
  71. Lee, C.K., et al., A study of the predonation hemoglobin and iron status among Hong Kong Chinese blood donors. Transfusion, 2013. 53(2): p. 322-7.
  72. Poon, C.M., S.S. Lee, and C.K. Lee, Variation of motivation between weekday and weekend donors and their association with distance from blood donation centres. Transfus Med, 2013. 23(3): p. 152-9.
  73. Reesink, H.W., et al., The use of the electronic (computer) cross-match. Vox Sang, 2013. 104(4): p. 350-64.
  74. Tsoi, W.C., N. Lelie, and C.K. Lin, Enhanced detection of hepatitis B virus in Hong Kong blood donors after introduction of a more sensitive transcription-mediated amplification assay. Transfusion, 2013. 53(10 Pt 2): p. 2477-88.
  75. Wong, D.K., et al., Role of HLA-DP polymorphisms on chronicity and disease activity of hepatitis B infection in Southern Chinese. PLoS One, 2013. 8(6): p. e66920.
  76. Wong, H.K., et al., Reduction in vasovagal reaction rate in young first-time blood donors by collecting 350 mL rather than 450 mL. Transfusion, 2013. 53(11): p. 2763-5.
  77. Wu, S.P., et al., MGUS prevalence in an ethnically Chinese population in Hong Kong. Blood, 2013. 121(12): p. 2363-4.
  78. Huang, F.Y., et al., Sequence Variations of Full-Length Hepatitis B Virus Genomes in Chinese Patients with HBsAg-Negative Hepatitis B Infection. PLoS One, 2014. 9(6): p. e99028.
  79. Lieberman, L., et al., Prevention of transfusion-transmitted cytomegalovirus (CMV) infection: Standards of care. Vox Sang, 2014.
  80. Pietersz, R.N., et al., Bacterial contamination in platelet concentrates. Vox Sang, 2014. 106(3): p. 256-83.
  81. So, B.K.L., et al., Evaluation of two chlorhexidine - alcohol-based skin disinfectants in blood donation setting. Vox Sanguinis, 2014. 106(4): p. 316-321.
  82. Wu, J.T., et al., Inferring influenza infection attack rate from seroprevalence data. PLoS Pathog, 2014. 10(4): p. e1004054.